Year: 2002
Type: article
Abstract: To the Editor: Vancomycin-resistant enterococci have become important nosocomial pathogens in the United States. Since November 1995, rectal swabs for surveillance for vancomycin-resistant enterococci have been collected twice weekly from adult patients admitted to the liver, kidney, and pancreas transplantation unit at our institution.1 Recently, linezolid-resistant, vancomycin-resistant Enterococcus faecium was isolated from seven patients at our institution. All isolates carried the vanA gene and were resistant to linezolid (minimal inhibitory concentration [MIC], 16 μg per milliliter), ampicillin, penicillin, gentamicin, streptomycin, and vancomycin and were susceptible to quinupristin–dalfopristin and the investigational agents oritavancin (MIC, 1 μg per milliliter) and tigecycline (MIC, . . .
Source: New England Journal of Medicine
Authors: Inmaculada A. Herrero, Nicolas C. Issa, Robin Patel
Institution: Mayo Clinic
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2089324618
